Cargando…

The prevalence of cardiac complications and their impact on outcomes in patients with non-traumatic subarachnoid hemorrhage

Subarachnoid hemorrhage (SAH) is a serious condition, and a myocardial injury or dysfunction could contribute to the outcome. We assessed the prevalence and prognostic impact of cardiac involvement in a cohort with SAH. This is a prospective observational multicenter study. We included 192 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Lång, Maarit, Jakob, Stephan M., Takala, Riikka, Lyngbakken, Magnus N., Turpeinen, Anu, Omland, Torbjørn, Merz, Tobias M., Wiegand, Jan, Grönlund, Juha, Rahi, Melissa, Valtonen, Mika, Koivisto, Timo, Røsjø, Helge, Bendel, Stepani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684538/
https://www.ncbi.nlm.nih.gov/pubmed/36418906
http://dx.doi.org/10.1038/s41598-022-24675-8
_version_ 1784835308871745536
author Lång, Maarit
Jakob, Stephan M.
Takala, Riikka
Lyngbakken, Magnus N.
Turpeinen, Anu
Omland, Torbjørn
Merz, Tobias M.
Wiegand, Jan
Grönlund, Juha
Rahi, Melissa
Valtonen, Mika
Koivisto, Timo
Røsjø, Helge
Bendel, Stepani
author_facet Lång, Maarit
Jakob, Stephan M.
Takala, Riikka
Lyngbakken, Magnus N.
Turpeinen, Anu
Omland, Torbjørn
Merz, Tobias M.
Wiegand, Jan
Grönlund, Juha
Rahi, Melissa
Valtonen, Mika
Koivisto, Timo
Røsjø, Helge
Bendel, Stepani
author_sort Lång, Maarit
collection PubMed
description Subarachnoid hemorrhage (SAH) is a serious condition, and a myocardial injury or dysfunction could contribute to the outcome. We assessed the prevalence and prognostic impact of cardiac involvement in a cohort with SAH. This is a prospective observational multicenter study. We included 192 patients treated for non-traumatic subarachnoid hemorrhage. We performed ECG recordings, echocardiographic examinations, and blood sampling within 24 h of admission and on days 3 and 7 and at 90 days. The primary endpoint was the evidence of cardiac involvement at 90 days, and the secondary endpoint was to examine the prevalence of a myocardial injury or dysfunction. The median age was 54.5 (interquartile range [IQR] 48.0–64.0) years, 44.3% were male and the median World Federation of Neurological Surgeons (WFNS) score was 2 (IQR 1–4). At day 90, 22/125 patients (17.6%) had left ventricular ejection fractions ≤ 50%, and 2/121 patients (1.7%) had evidence of a diastolic dysfunction as defined by mitral peak E-wave velocity by peak eʹ velocity (E/eʹ) > 14. There was no prognostic impact from echocardiographic evidence of cardiac complications on neurological outcomes. The overall prevalence of cardiac dysfunction was modest. We found no demographic or SAH-related factors associated with 90 days cardiac dysfunction.
format Online
Article
Text
id pubmed-9684538
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-96845382022-11-25 The prevalence of cardiac complications and their impact on outcomes in patients with non-traumatic subarachnoid hemorrhage Lång, Maarit Jakob, Stephan M. Takala, Riikka Lyngbakken, Magnus N. Turpeinen, Anu Omland, Torbjørn Merz, Tobias M. Wiegand, Jan Grönlund, Juha Rahi, Melissa Valtonen, Mika Koivisto, Timo Røsjø, Helge Bendel, Stepani Sci Rep Article Subarachnoid hemorrhage (SAH) is a serious condition, and a myocardial injury or dysfunction could contribute to the outcome. We assessed the prevalence and prognostic impact of cardiac involvement in a cohort with SAH. This is a prospective observational multicenter study. We included 192 patients treated for non-traumatic subarachnoid hemorrhage. We performed ECG recordings, echocardiographic examinations, and blood sampling within 24 h of admission and on days 3 and 7 and at 90 days. The primary endpoint was the evidence of cardiac involvement at 90 days, and the secondary endpoint was to examine the prevalence of a myocardial injury or dysfunction. The median age was 54.5 (interquartile range [IQR] 48.0–64.0) years, 44.3% were male and the median World Federation of Neurological Surgeons (WFNS) score was 2 (IQR 1–4). At day 90, 22/125 patients (17.6%) had left ventricular ejection fractions ≤ 50%, and 2/121 patients (1.7%) had evidence of a diastolic dysfunction as defined by mitral peak E-wave velocity by peak eʹ velocity (E/eʹ) > 14. There was no prognostic impact from echocardiographic evidence of cardiac complications on neurological outcomes. The overall prevalence of cardiac dysfunction was modest. We found no demographic or SAH-related factors associated with 90 days cardiac dysfunction. Nature Publishing Group UK 2022-11-22 /pmc/articles/PMC9684538/ /pubmed/36418906 http://dx.doi.org/10.1038/s41598-022-24675-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Lång, Maarit
Jakob, Stephan M.
Takala, Riikka
Lyngbakken, Magnus N.
Turpeinen, Anu
Omland, Torbjørn
Merz, Tobias M.
Wiegand, Jan
Grönlund, Juha
Rahi, Melissa
Valtonen, Mika
Koivisto, Timo
Røsjø, Helge
Bendel, Stepani
The prevalence of cardiac complications and their impact on outcomes in patients with non-traumatic subarachnoid hemorrhage
title The prevalence of cardiac complications and their impact on outcomes in patients with non-traumatic subarachnoid hemorrhage
title_full The prevalence of cardiac complications and their impact on outcomes in patients with non-traumatic subarachnoid hemorrhage
title_fullStr The prevalence of cardiac complications and their impact on outcomes in patients with non-traumatic subarachnoid hemorrhage
title_full_unstemmed The prevalence of cardiac complications and their impact on outcomes in patients with non-traumatic subarachnoid hemorrhage
title_short The prevalence of cardiac complications and their impact on outcomes in patients with non-traumatic subarachnoid hemorrhage
title_sort prevalence of cardiac complications and their impact on outcomes in patients with non-traumatic subarachnoid hemorrhage
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684538/
https://www.ncbi.nlm.nih.gov/pubmed/36418906
http://dx.doi.org/10.1038/s41598-022-24675-8
work_keys_str_mv AT langmaarit theprevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT jakobstephanm theprevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT takalariikka theprevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT lyngbakkenmagnusn theprevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT turpeinenanu theprevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT omlandtorbjørn theprevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT merztobiasm theprevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT wiegandjan theprevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT gronlundjuha theprevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT rahimelissa theprevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT valtonenmika theprevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT koivistotimo theprevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT røsjøhelge theprevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT bendelstepani theprevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT langmaarit prevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT jakobstephanm prevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT takalariikka prevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT lyngbakkenmagnusn prevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT turpeinenanu prevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT omlandtorbjørn prevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT merztobiasm prevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT wiegandjan prevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT gronlundjuha prevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT rahimelissa prevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT valtonenmika prevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT koivistotimo prevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT røsjøhelge prevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage
AT bendelstepani prevalenceofcardiaccomplicationsandtheirimpactonoutcomesinpatientswithnontraumaticsubarachnoidhemorrhage